Group 1 - The company's board of directors held its 16th meeting of the 10th session on September 22, 2025, in Shanghai, with 8 out of 9 directors present [2][3] - The meeting was legally convened and followed the necessary procedures as per the Company Law and the company's articles of association [2][3] Group 2 - The board approved the election of Mr. Li Junhua as the chairman of the board, with a term lasting until the end of the current board session [3][4] - The board also approved the appointment of Mr. Li Junhua as the chairman of the strategic committee [5][6] Group 3 - The third extraordinary general meeting of shareholders was also held on September 22, 2025, at the same location [8][10] - The meeting was conducted with a combination of on-site and online voting, complying with legal and regulatory requirements [10]

Core Points - The company has completed the registration of changes and has received a new business license following the cancellation of its supervisory board and amendments to its articles of association [1][2] - The company's registered address has been updated due to administrative division adjustments, although the actual location remains unchanged [1] - The company operates in the production and sale of various equipment, including air separation equipment, LNG equipment, and environmental protection devices [1] Company Information - Company Name: Hangzhou Fostar Cryogenic Equipment Co., Ltd [1] - Unified Social Credit Code: 91330100723604713X [1] - Legal Representative: Ge Haojun [1] - Registered Capital: 160 million [1] - Established Date: July 4, 2000 [1] - New Address: No. 398, Xingqi Road, Hangzhou Linping Economic and Technological Development Zone, Hangzhou, Zhejiang Province [1] Business Scope - Production: Air separation equipment, LNG equipment, tubular heat exchangers, storage tanks, complete sets of devices for coke oven gas recovery, and wastewater treatment [1] - Wholesale and Retail: Air separation equipment, LNG equipment, tubular heat exchangers, environmental protection equipment, and electronic products [1] - Services: Design and technical consulting for general machinery parts, environmental products, and general equipment [1]

证券代码：600749 证券简称：西藏旅游 公告编号：2025-041号 西藏旅游股份有限公司 关于召开2025年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： 召开时间：2025年9月30日(星期二)上午10:00-11:00 召开地点：上海证券交易所上证路演中心（网址：https://roadshow.sseinfo.com/） 召开方式：上证路演中心网络文字互动 投资者可于2025年9月23日至9月29日16:00前登录上证路演中心网站首页点击"提问预征集"栏目或通过 公司邮箱提问，公司将在说明会上解答投资者普遍关注的问题。 西藏旅游股份有限公司（以下简称"公司"）已于2025年8月20日发布2025年半年度报告，为便于广大投 资者深入了解公司2025年上半年经营情况，公司拟召开本次业绩说明会，与广大投资者互动交流。 一、说明会类型 本次半年度业绩说明会以网络文字互动的方式召开。 二、说明会召开的时间、地点 会议召开时间：2025年9月30日上午10:00-11:00 会议召开方式 ...

Core Viewpoint - Chengdu Xuguang Electronics Co., Ltd. is set to hold a half-year performance briefing on October 9, 2025, to discuss its operational results and financial status for the first half of 2025, allowing investors to engage in Q&A sessions [2][3][4]. Group 1: Meeting Details - The performance briefing will take place on October 9, 2025, from 15:00 to 16:00 [5]. - The event will be held at the Shanghai Stock Exchange Roadshow Center and will be conducted in an interactive online format [4][5]. - Investors can submit questions from September 24 to September 30, 2025, through the Roadshow Center website or via the company's email [2][6]. Group 2: Participation Information - Investors can participate in the briefing by logging into the Shanghai Stock Exchange Roadshow Center on the scheduled date and time [4][5]. - The company will address commonly asked questions during the briefing, ensuring transparency and engagement with investors [3][6]. - Contact information for inquiries includes Mr. Xiong Shangrong, with a provided email and phone number for further assistance [6].

证券代码：600200 证券简称：*ST苏吴 公告编号：临2025-112 江苏吴中医药发展股份有限公司 关于盐酸林可霉素注射液通过仿制药一致性评价的公告 本公司董事会及董事会全体成员保证公告内容不存在虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实、准确和完整承担个别及连带责任。 近日，江苏吴中医药发展股份有限公司（以下简称"公司"）全资子公司江苏吴中医药集团有限公司下属 分支机构江苏吴中医药集团有限公司苏州制药厂（以下简称"苏州制药厂"）收到了国家药品监督管理局 （以下简称"国家药监局"）核准签发的关于"盐酸林可霉素注射液"（以下简称"该药品"或"本品"）的 《药品补充申请批准通知书》（通知书编号：2025B04321），该药品通过仿制药质量和疗效一致性评 价（以下简称"仿制药一致性评价"）。现将相关情况公告如下： 一、药品基本情况 二、药品的其他相关情况 药品名称：盐酸林可霉素注射液 剂型：注射剂 规格：2ml：0.6g（按C18H34N2O6S计） 药品批准文号：国药准字H32021365 注册分类：化学药品 上市许可持有人：江苏吴中医药集团有限公司苏州制药厂 药品生产企业：江苏吴中医药集团有限公 ...

Group 1 - The announcement details the exit of Guokai Development Fund Co., Ltd. from its investment in Hunan Changgao Electric Co., Ltd. through a capital reduction process [1][5] - In December 2015, the company and Guokai Fund signed an investment contract where Guokai Fund invested 150 million yuan, acquiring a 40% stake in Changgao Electric [2] - Guokai Fund received an annual investment return of 1.2% and has been repaid all principal and interest by Changgao Electric, leading to its exit through capital reduction [3] Group 2 - On September 19, 2025, Changgao Electric completed the business registration change following Guokai Fund's exit, with a registered capital of 150 million yuan [4] - The company remains a wholly-owned subsidiary of Changgao Electric Technology Co., Ltd., and the capital reduction does not affect the consolidated financial statements of the company [5]

Core Viewpoint - The announcement details the completion of the share reduction plan by a major shareholder, Yili Group, for Fujian Nanping Sun Cable Co., Ltd, indicating a decrease in their shareholding percentage and compliance with relevant regulations [2][4]. Group 1: Share Reduction Plan - Yili Group planned to reduce its holdings by up to 21,670,011 shares, representing 3% of the total share capital, through centralized bidding and block trading from June 20, 2025, to September 19, 2025 [2]. - As of August 4, 2025, Yili Group had reduced its holdings by 5,641,195 shares, accounting for 0.78% of the total share capital, bringing their ownership down from 17.36% to 16.58% [3]. - By the end of the reduction plan on September 19, 2025, Yili Group had cumulatively reduced its holdings by 7,223,295 shares, which is 1% of the total share capital, resulting in a new ownership percentage of 16.36% [3][4]. Group 2: Compliance and Impact - The share reduction was conducted in strict accordance with the Securities Law of the People's Republic of China and other relevant regulations, ensuring no violations occurred [4]. - The reduction plan was consistent with previously disclosed intentions, and the number of shares reduced fell within the announced plan, indicating no breach of commitments [4]. - Yili Group is not the controlling shareholder of the company, and the reduction will not affect the company's governance structure or ongoing operations [4].

Meeting Overview - The third extraordinary general meeting of shareholders was held on September 22, 2025, at 14:30 [4][5] - The meeting was conducted through a combination of on-site and online voting [5] Attendance - A total of 265 shareholders attended the meeting, representing 384,464,551 shares, which is 54.02% of the total voting shares [9] - Among them, 4 shareholders attended in person, representing 309,631,172 shares (43.51%), while 261 shareholders participated via online voting, representing 74,833,379 shares (10.51%) [9][10] Proposals and Voting Results - The following proposals were approved during the meeting: 1. **Establishment of the Compensation Management System for Directors and Senior Management**: Approved by 99.65% of the votes [14] 2. **Amendment of the External Guarantee System**: Approved by 99.32% of the votes [15] 3. **Amendment of the Fund Management System**: Approved by 99.35% of the votes [16] 4. **Amendment of the Financial Derivatives Trading Management System**: Approved by 99.36% of the votes [17] 5. **Amendment of the Selection of Accounting Firms System**: Approved by 99.33% of the votes [18] 6. **Reappointment of Accounting Firms**: Approved by 99.65% of the votes [19] 7. **2025 Semi-Annual Profit Distribution Plan**: Approved by 99.69% of the votes [20] 8. **Employee Stock Ownership Plan (Draft) and Summary**: Approved by 97.04% of the votes [21] 9. **Employee Stock Ownership Plan Management Measures**: Approved by 97.05% of the votes [22] 10. **Authorization for the Board to Handle Matters Related to the 2025 Employee Stock Ownership Plan**: Approved by 96.98% of the votes [23] Legal Opinion - The legal opinion provided by Guohao Law Firm confirmed that the meeting's procedures, qualifications of attendees, voting procedures, and results complied with relevant laws and regulations [24]

Core Viewpoint - The company plans to invest in the "Zhengzhou Airport Advanced Computing Phase II Venture Capital Fund" with a total investment of up to RMB 50 million, aiming to acquire equity in Chaoyuan Digital Technology Co., Ltd. to achieve investment returns through equity appreciation [2][3][9]. Investment Overview - The company will participate in the fund as a limited partner, contributing RMB 24.4 million, which represents approximately 34.164% of the fund's total size of RMB 71.42 million [3][9]. - The total investment amount from the company, including previous contributions, will be RMB 49.9 million, within the authorized limit set by the board [2][9]. Fund Structure and Management - The fund is structured as a limited partnership, with Zhengzhou Airport Private Fund Management Co., Ltd. acting as the general partner [12][29]. - The fund's lifespan is set for five years, with a three-year investment period and a two-year exit period, extendable by unanimous agreement among partners [31]. Investment Strategy - The fund aims to acquire equity in Chaoyuan Digital Technology Co., Ltd. through a transfer agreement, with the goal of asset appreciation [29][30]. - The investment decision-making process is centralized with the general partner, who will manage the fund's operations and represent it externally [31]. Financial Implications - The investment is not expected to adversely affect the company's normal operations or cash flow, aligning with the interests of the company and its shareholders [38]. - The investment is anticipated to enhance the company's investment structure and improve capital investment returns through a professional management team [39].

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002031 证券简称：巨轮智能 公告编号：2025-042 巨轮智能装备股份有限公司 关于控股股东部分股份解除质押和质押的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 巨轮智能装备股份有限公司（以下简称"公司"）近日接到控股股东吴潮忠先生函告，获悉其所持有的公 司的部分股份办理了解除质押和质押的业务，具体事项如下： 一、本次解除质押基本情况 ■ 上述股份的质押情况，详见公司于2024年9月4日在《中国证券报》《证券时报》《上海证券报》及巨潮 资讯网披露的《关于控股股东部分股份质押延期购回、解除质押及质押的公告》。 二、本次股份质押基本情况 ■ 四、控股股东股份质押情况 1、公司控股股东吴潮忠先生股份质押与公司生产经营需求无关。 2、公司控股股东吴潮忠先生未来半年内到期的质押股份累计数量为3,880万股，占其所持股份比例 14.97%，占公司总股本比例1.76%，对应融资余额5,490万元，还款来源为自筹资金；未来一年内到期的 质押股份累计数量为13,140万股，占其所持股份比例50.69%， ...